Redhill Biopharma
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Cash | 5,159 | 3,971 | 3,971 | 1,348 |
Basic Shares | 60,809,201 | 3,159 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $286 | $8,043 | $6,530 | $61,800 |
Gross Profit | 286 | 4,851 | 3,071 | 28,463 |
EBITDA | -7,652 | -7,594 | 26,273 | -22,182 |
EBIT | -8,061 | -8,213 | 24,283 | -30,336 |
Net Income | -429 | -8,268 | 23,916 | -71,669 |
Net Change In Cash | 286 | 8,043 | 6,530 | 61,800 |
Free Cash Flow | -9,656 | -9,378 | -35,831 | -29,383 |
Cash | 3,971 | 4,617 | 5,569 | 19,968 |
Basic Shares | 3,159 | 2,464 | 518 | 123 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | $0 |
2025-09-30 | $0 |
2025-06-30 | -$2.29 |
2025-03-31 | -$4.02 |